Figure 1.
EGCG markedly improved the growth rate and liver functioning in bile duct-ligated (BDL) rats. (A) Changes in body weight. (B) Representative H&E liver histology (40×) and blinded quantitative assessment of liver necrosis and inflammation. (C) Sirius Red staining and (D) liver hydroxyproline analysis demonstrated reduced liver fibrosis in the livers of EGCG-treated BDL rats. bP<0.05 vs the sham-operated group. eP<0.05 vs the BDL group. n=10 in each group.